Stocktoria
Nexentis Technologies Inc. NXTS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2010-05-26
Nexentis Technologies Inc. statistics & valuation
Market cap$7.3M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | 21.4% | 79.0% | 59.8% | 69.0% |
| Operating margin | — | -1563.3% | -2876.5% | -1477.1% | -1073.5% |
| Net margin | — | -2472.9% | -2475.7% | -1456.7% | -1100.2% |
| FCF margin | — | — | — | -1306.8% | -954.3% |
| Return on assets | -19.6% | -95.0% | -90.0% | -88.4% | -63.5% |
| Return on equity | -25.0% | -109.3% | -100.6% | -98.2% | -74.4% |
| Debt / equity | — | — | — | — | 0.00× |
| Current ratio | 4.19 | 3.87 | 7.02 | 8.77 | 7.76 |
| Revenue growth | — | -20.3% | -33.1% | -10.1% | 88.6% |
Source: SEC EDGAR filings · CIK 0001789192 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.